Brian Van Tine, MD, PhD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Agenus
    Topic:
    Ad Board Meeting
    Date added:
    06/11/2024
    Date updated:
    06/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Iterion Therapeutics, Inc
    Topic:
    Ad Board Meeting
    Date added:
    06/11/2024
    Date updated:
    06/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Curis
    Topic:
    Ad Board Meeting
    Date added:
    06/11/2024
    Date updated:
    06/20/2024

Pages

Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology